(Q50795585)

19 March 2018

title

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. (English)

1 reference

19 March 2018

0 references

Richard D Moore

1

1 reference

19 March 2018

Jeanne C Keruly

series ordinal

2

1 reference

19 March 2018

language of work or name

English

0 references

publication date

20 December 2006

1 reference

19 March 2018

Clinical Infectious Diseases

published in

1 reference

19 March 2018

volume

44

1 reference

19 March 2018

page(s)

441-446

1 reference

19 March 2018

issue

3

1 reference

19 March 2018

Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level

cites work

1 reference

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

21 January 2018

1 reference

Factors Influencing Increases in CD4 Cell Counts of HIV‐Positive Persons Receiving Long‐Term Highly Active Antiretroviral Therapy

21 January 2018

1 reference

Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count

21 January 2018

1 reference

Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study

21 January 2018

1 reference

Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy

21 January 2018

1 reference

Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program

21 January 2018

1 reference

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

21 January 2018

1 reference

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

21 January 2018

1 reference

Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study).

21 January 2018

1 reference

A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts

21 January 2018

1 reference

Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.

21 January 2018

1 reference

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

21 January 2018

1 reference

CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/510746

1 reference

19 March 2018

PubMed ID

17205456

1 reference

19 March 2018